Presentation at the FDA’s Public Meeting on the Recommendations for Prescription Drug User Fee Act (PDUFA) Reauthorization
View the complete testimony as PDF
In its presentation at the Food and Drug Administration’s (FDA’s) meeting to discuss the reauthorization of the Prescription Drug User Fee Act (PDUFA) and specifically the draft commitment language soon to be sent to Congress requesting that reauthorization, Public Citizen offered the FDA specific suggestions to modify their commitment language in order to increase the public health and regulatory focus of the FDA’s drug and biologic review programs.
See Public Citizen’s other work regarding the drug approval process.